You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Details for Patent: 8,815,884

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,815,884 protect, and when does it expire?

Patent 8,815,884 protects JESDUVROQ and is included in one NDA.

This patent has thirty-six patent family members in thirty-one countries.

Summary for Patent: 8,815,884

Title:	Prolyl hydroxylase inhibitors
Abstract:	The invention described herein relates to certain pyrimidinetrione N-substituted glycine derivatives of formula (I)
Inventor(s):	Fitch Duke M., Shaw Antony N., Wiggall Kenneth
Assignee:	GlaxoSmithKline LLC
Application Number:	US14026164
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 8,815,884

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Glaxosmithkline	JESDUVROQ	daprodustat	TABLET;ORAL	216951-001	Feb 1, 2023		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE	⤷ Sign Up
Glaxosmithkline	JESDUVROQ	daprodustat	TABLET;ORAL	216951-002	Feb 1, 2023		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE	⤷ Sign Up
Glaxosmithkline	JESDUVROQ	daprodustat	TABLET;ORAL	216951-003	Feb 1, 2023		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE	⤷ Sign Up
Glaxosmithkline	JESDUVROQ	daprodustat	TABLET;ORAL	216951-004	Feb 1, 2023		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE	⤷ Sign Up
Glaxosmithkline	JESDUVROQ	daprodustat	TABLET;ORAL	216951-005	Feb 1, 2023		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,815,884

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	061570	⤷ Sign Up
Australia	2007260837	⤷ Sign Up
Brazil	PI0713446	⤷ Sign Up
Canada	2655491	⤷ Sign Up
China	101505752	⤷ Sign Up
Costa Rica	10534	⤷ Sign Up
Cyprus	1115011	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.